Skip to main content

Table 1 Baseline characteristics of the study population, stratified by echocardiographic criteria of HCM 1,3

From: Use of a highly-sensitive cardiac troponin I assay in a screening population for hypertrophic cardiomyopathy: a case-referent study

 

Total (n = 107)

Normal screening echo (n=64)

Borderline HCM (n=24)

Definite HCM (n=19)

 

Demographic data

Age in years: mean [SD]

39.30 (13.86)

35.63 [12.26]

44.92 [12.793]

44.59 [16.63]

F=6.15, p=0.003

Male sex: n (%)

63 (58002E9%)

32 (50.0%)

20 (83.3%)

11 (57.9%)

Χ2=8.01, p=0.018

BMI in kg/m 2 : mean [SD]

26.94 (3.90)

25.67 (3.90)

29.08 [3.88]

27.70 [3.07]

F=5.97, p=0.004

Relationship to the family proband

     

Proband: n (%)

8 (7.5%)

0 (0%)

1 (4.2%)

7 (36.85%)

Fishers exact p<0.005

1 st degree relative : n (%)

82 (76.6%)

53 (82.8%)

20 (83.3%)

9 (47.4%)

 

2 nd degree or higher : n (%)

17 (15.9%)

11 (17.2%)

3 (12.5%)

3 (15.8%)

 

Clinical History

Any symptoms: n (%)

36 (33.6%)

18 (28.1%)

8 (33.3%)

10 (52.5%)

Χ2=3.94, p=0.139

Chest pain: n (%)

10 (9.4%)

7 (10.9%)

2 (8.3%)

1 (5.3%)

 

Dyspnoea: n(%)

12 (11.2%)

5 (7.8%)

3 (12.5%)

4 (21.1%)

Fishers exact p=0.267

Palpitations: n(%)

17 (15.9%)

7 (10.9%)

4 (16.7%)

6 (31.6%)

Fishers exact p=0.089

History of syncope: n(%)

6 (5.6%)

2 (3.1%)

2 (8.3%)

2 (10.5%)

Fishers exact p=0.286

  1. BMI Body Mass Index.